Blood · 2011 · 100 citations · 34 references
Life SciencesHematologyImmunologyAutoimmunityImmunopathologyInnate ImmunityAntiphospholipid SyndromeAutoantibodiesComplement DisordersComplement RegulationComplement SystemComplement-mediated InjuryAnti-beta-2 Glycoprotein I AntibodiesAnti-phospholipid AntibodiesComplement Cascade MechanismsComplement DysregulationComplement Regulator TargetingComplement System AbnormalitiesHuman Complement Regulatory Proteins
The human plasma protein β(2)-glycoprotein I (β(2)-GPI) is the major target of autoantibodies associated with antiphospholipid syndrome. However, the biologic function of this abundant protein is still unclear. Here we identify β(2)-GPI as a complement regulator. β(2)-GPI circulates in the plasma in an inactive circular form. On surface binding, such as to apoptotic cells, β(2)-GPI changes conformation to an elongated form that acquires C3/C3b binding activities. β(2)-GPI apparently changes conformation of C3, so that the regulator factor H attaches and induces subsequent degradation by the protease factor I. β(2)-GPI also mediates further cleavage of C3/C3b compared with factor H alone. Our data provide important insights into innate immune regulation by plasma protein β(2)-GPI, which may be exploited in the prevention and therapy of autoimmune disease antiphospholipid syndrome.
34
H. Patrick McNeil, Richard J. Simpson, C.N. Chesterman et al. · Proceedings of the National Academy of Sciences · 1990 · 1.6K citations
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
Mónica Galli, Tiziano Barbui, Paul Comfurius et al. · The Lancet · 1990 · 1.3K citations · Full text
Debra Gershov, SunJung Kim, Nathan Brot et al. · The Journal of Experimental Medicine · 2000 · 695 citations · Full text
Life Sciences, Immunology, Pathology +17